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Abstract
The interaction between prM and E proteins in flavivirus-infected cells is a major driving force for the assembly of 
flavivirus particles. We used site-directed mutagenesis to study the potential role of the transmembrane domains of 
the prM proteins of Japanese encephalitis virus (JEV) in prM-E heterodimerization as well as subviral particle formation. 
Alanine insertion scanning mutagenesis within the GXXXG motif in the first transmembrane segment of JEV prM 
protein affected the prM-E heterodimerization; its specificity was confirmed by replacing the two glycines of the 
GXXXG motif with alanine, leucine and valine. The GXXXG motif was found to be conserved in the JEV serocomplex 
viruses but not other flavivirus groups. These mutants with alanine inserted in the two prM transmembrane segments 
all impaired subviral particle formation in cell cultures. The prM transmembrane domains of JEV may play importation 
roles in prM-E heterodimerization and viral particle assembly.
Background
Japanese encephalitis virus (JEV) is a small enveloped
positive-strand RNA virus that belongs to the genus Fla-
vivirus of the family Flaviviridae [1,2]. The RNA genome
of all flaviviruses contain sequences that code for three
structural protein genes (capsid C, membrane precursor
prM, and envelope E) and seven non-structural protein
genes (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5), as
well as flanking un-translated regions [1,2]. The flavivirus
assembly process includes (i) interaction of prM and E
proteins by heterodimer formation in the endoplasmic
reticulum (ER), (ii) encapsulation of the genomic RNA by
the C protein and enclosure by cell membrane-derived
lipid bilayers containing prM and E proteins to form
immature virions, and (iii) cleavage of the prM protein to
M protein by furin or a furin-like protease in the trans-
Golgi network (TGN) to release viral particles. Subviral
particles (SPs) that do not contain genomic RNA and pro-
tein C have been found in flavivirus-infected cells [3]. Co-
expression of prM and E envelope proteins resulted in the
formation and secretion of SPs in cell cultures for tick-
borne encephalitis virus (TBEV) [4], dengue virus
(DENV) [5], JEV [6,7], Murray Valley encephalitis virus
(MVEV) [8], St. Louis encephalitis virus (SLEV) [9], and
West Nile virus (WNV) [10]. The interaction of prM and
E proteins in flavivirus-infected cells is a major driving
force of the assembly of virus although assembly mecha-
nisms of the Flaviviridae  are only very incompletely
understood.
The prM and E envelope proteins are type I transmem-
brane (TM) proteins and both contain stem and anchor
regions at their C-terminal ends [11] as illustrated in Fig.
1 The stem region of the prM protein contains one helix
domain (prM-H), and that of the E protein has two helix
domains (E-H1, E-H2). The anchor regions of the prM
and E proteins both contain two separate anchor domains
(prM-TM1, prM-TM2, E-TM1, E-TM2). The stem and
anchor regions of the prM and E proteins of DENV have
both been predicted to include two alpha-helices [12].
High-resolution cryo-EM images of DENV show that the
prM-H domain is partially buried in the outer lipid leaflet
while the E-H1 and E-H2 domains are either angled or lie
flat on the outer lipid leaflet [12]. The TM anchor regions
of prM and E proteins (prM-TM1, prM-TM2, E-TM1, E-
TM2) all form anti-parallel coiled-coil helices and do not
penetrate the lipid membranes to come in contact with
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nucleocapsids [12]. In TBEV, the E-TM1 and E-H2
domains substantially influenced the stability of the prM-
E interaction but did not affect the prM-mediated intrac-
ellular transport or secretion of soluble E protein accord-
ing to C-terminal deletion analysis [13]. However, alanine
insertion scanning mutagenesis in the anchor regions of
prM and E of yellow fever virus (YFV) did not affect the
prM-E interaction, but did inhibit SP formation [14].
Replacement of the stem and anchor regions of the E pro-
tein of DENV with that of JEV promoted SP production
[15] but the E-H1 domain of JEV did not influence the SP
secretion of DENV in CHO cells [16]. The E-TM2
domain of TBEV was demonstrated to be associated with
virus particle formation, acting as a signal peptide for
NS1 protein [17]. To our knowledge, most reported stud-
ies have focused on the stem and anchor regions of the E
protein, and very little information is available for the
prM protein.
In this work, the two anchor domains of prM protein
(prM-TM1, prM-TM2) were studied using alanine inser-
tion scanning mutagenesis to disrupt the helix-helix for-
mation, and their roles in prM-E interaction and SP
formation were characterized. Our earlier work has dem-
onstrated that intracellular formation of the prM-E com-
plex of JEV envelope proteins can be detected using
baculovirus coexpression of prM and E in trans, and that
the His-99 of prM significantly influences the prM-E
interaction [18]. This paper reports that the GXXXG
motif in the prM-TM1 domain influences the formation
of prM-E heterodimers in infected cells. All of the
mutants with alanine inserted in the prM-TM1 or prM-
TM2 segment inhibited SP formation in culture superna-
tants, suggesting that the two TM segments of prM may
play important roles for JEV particle assembly.
Methods
Cell lines and viruses
Spodoptera frugiperda Sf9 cells were grown at 28°C in
TNM-FH medium (Sigma) supplemented with 10% fetal
bovine serum (FBS). Hybridoma cells for production of
the monoclonal antibodies (mAbs) 5B1 (anti-JEV prM)
and E3.3 (anti-JEV E) were grown at 37°C in ISCOVE's
modified Dulbecco's medium (Invitrogen) supplemented
with 10% FBS. The JEV strain CH2195LA [Gen-
Bank:AF221499] [19,20] and recombinant baculoviruses
were produced and propagated in Sf9 cells.
Construction of recombinant baculoviruses
Plasmid pUC18-prME containing nucleotides 414 to
2477 from JEV virus strain CH2195LA was the parent
construct used for alanine-insertion mutants, substitu-
tion mutants and wild type controls. Alanine-insertion
mutants at appropriate positions of prM were con-
structed using overlapping PCR. Substitution mutants at
Figure 1 Schematic dagram of flavivirus prM and E protein where the stem and anchor regions located at their C-terminal ends.Lin et al. Journal of Biomedical Science 2010, 17:39
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position 142 and 146 of prM were also constructed using
overlapping PCR. All constructs contained BamHI and
EcoRI restriction sites for ligation to the pBlueBac4 bacu-
lovirus vector (Invitrogen). The constructed recombinant
pBlueBac4 plasmids were co-transfected with a linearized
baculovirus Bac-N-Blue DNA (Invitrogen) to Sf9 cells
treated with Cellfectin (Invitrogen) and incubated for 5-7
days. Recombinant baculoviruses were obtained from the
blue-stained plaques formed in the infected Sf9 cells
overlaid with agarose medium that contained 5-bromo-4-
chloro-3-indoyl-β-D-galactoside (X-gal). Three plaque
purifications were performed to obtain the recombinant
baculoviruses that were used in this study.
Western blotting
Sf9 cells co-infected with recombinant baculoviruses
were harvested and analyzed with 12% SDS-PAGE under
reducing condition. Infected cell lysates were electrically
transferred onto the nitro-cellulose membranes, blocked
by 5% skim milk, and reacted with mAbs 5B1 and E3.3,
respectively. As an internal control, the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was parallel used
and detected by anti-GAPDH mAb (SignalChem). All of
these samples were then reacted with anti-mouse IgG
conjugated to peroxidase (KPL) and visualized using ECL
(PerkinElmer).
RNA extraction and complementary DNA preparation by RT
The co-infected Sf9 cells at 3 days post infection were
harvested and immediately extracted for total RNAs
using RNeasy mini kit (Qiagen) according to the protocol
of the supplier, and subsequently quantified with a Nano-
Drop ND-1000 spectrophotometer (NanoDrop Technol-
ogies). RNA purity was estimated by the absorbance ratio
A260/A280. The calculated ratios were in the range of 1.8 to
1.9 from the indicated samples and indicate high purity
RNAs. One microgram total RNA was reverse tran-
scribed using the M-MLV Reverse Transcriptase (Pro-
mega) with 250 ng random hexamer primers (Invitrogen)
according to the manufacturer's instructions, without an
RNase inhibitor in a final volume of 20 μL. The mixture
was incubated for one hour at 37°C.
Quantitative real-time PCR
Quantitative real-time PCR was performed in white
LightCycler 480 Multiwell Plate 96 plates (Roche) in a
final reaction volume of 10 μL. For detection of prM
mRNA transcripts [GenBank:AF221499]: Forward
primer 5'- aggaatcctggctacgcttt -3', reverse primer 5'-cgtt-
gttactgccaagcatc -3' and specific probe 5'-ggcggcgg -3'.
For detection of E mRNA transcripts [Gen-
Bank:AF221499]: Forward primer 5'- gaaggggagcattgaca-
cat -3', reverse primer 5'-gattgttctcccaatcgcttt-3' and
specific probe 5'-ttctcctg -3'. For detection of GAPDH
mRNA transcripts [GenBank:NM_080369]: Forward
primer 5'-aagggaatcctgggctacac-3', reverse primer 5'-aat-
gggtgtcgctgaagaag-3' and specific probe 5'-ggaggtgg -3'.
According to the primer optimization matrix, varying
amounts of the forward and reverse primer (Invitrogen)
of 100 nmol/L, 200 nmol/L, and 300 nmol/L were mixed
in 1× LightCycler 480 Probes Master (Roche) containing
100 nmol/L and 200 nmol/L of the human Universal
Probe Library probe (Roche), respectively, and 1.0 μL of
c D N A  a s  t e m p l a t e  ( 1 : 2 0 ,  t a k e n  f r o m  o n e  a p p r o p r i a t e
source described above, but consistent throughout a sin-
gle experiment). The initial denaturation (95°C, 10 min-
utes) was followed by 45 cycles of 10 seconds at 95°C, 30
seconds at 60°C, and a final cooling step at 40°C for 10
seconds. Each primer concentration combination was
analyzed in duplicate for each cDNA source used.
PNGaseF and EndoH glycosidase treatment of glycoprotein
Sf9 cells infected by recombinant baculoviruses were har-
vested and lysed using a lysis buffer for 3 hours at 4°C.
Then, 10X glycoprotein denaturing buffer (New England
BioLab) was added to the cell lysate to a 1X concentration
and the whole was boiled at 95°C for 5 minutes. Subse-
quently, 14 μL of denatured sample was mixed with 2 μL
10X G7 buffer, 2 μL 10% NP-40, and 2 μL PNGaseF or
EndoH to yield a 20 μL reaction mixture. Finally, the reac-
tion mixtures were left to stand at 37°C for 3 hours to
allow deglycosylation.
Confocal laser scanning microscopic analysis for subcellular 
localization
Infected Sf9 cells that had been grown on 15 mm glass
coverslips for 24 hour post infection (hpi) were washed
three times in TBS (140 mM NaCl; 25 mM Tris-HCl, pH
6.1) incubated in a medium that contained 10 nM
DiIC13(3) (an ER-staining dye, Molecular Probes) for 30
min, and finally fixed with 3.7% paraformaldehyde for 1 h.
The cells were then permeabilized for 1 h with TBS con-
taining 0.1% Triton X-100. The expression of JEV pro-
teins in these cells was revealed by staining with the anti-
E mAb E3.3 or anti-prM mAb 5B1 followed by goat anti-
mouse Alexa Fluor 647 IgG (Molecular Probes). The sub-
cellular localizations in these cells were examined by con-
focal laser scanning microscopy (Zeiss LSM 500) using a
100x 1.3 oil objective.
Metabolic labeling and sucrose gradient sedimentation 
analysis
Subconfluent monolayers of Sf9 cells grown in 6-well
plates were infected with recombinant baculoviruses at
multiplicity of infection (MOI) = 5. At 24 hpi, the TNM-
FH medium was removed and replaced with TNM-FH
medium that contained 0.01% normal methionine (Met)
and 0.02-0.10 mCi/mL of [35S]methionine/cysteine. Bac-Lin et al. Journal of Biomedical Science 2010, 17:39
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ulovirus-infected Sf9 cells were treated with a lysis buffer
(50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 2 mM EDTA,
1% Triton X-100 and 1 mM phenylmethylsufonylfluo-
ride), and then pre-cleared using protein A Sepharose
(Pharmacia). Each purified cell lysate was layered on a 3-
60% (wt/wt) sucrose gradient in gradient buffer (50 mM
Tris-HCl [pH 8.0], 150 mM NaCl, 2 mM EDTA, 0.5% Tri-
ton X-100, 1 mM phenylmethylsufonylfluoride). The gra-
dients were centrifuged in a Hitachi RPS40ST rotor at
38,000 rpm and 15°C for 22 h. After centrifugation, each
fraction was collected, immunoprecipitated using mAb
E3.3 (anti-JEV E protein) and incubated for 5 h at 4°C;
then protein A Sepharose slurry was added and the sys-
tem was incubated for another 16 h under the same con-
ditions. The immunoprecipitates were separated by
centrifugation at 2500 rpm for 3 min and the pellets thus
f o r m e d  w e r e  w a s h e d  t w i c e  w i t h  i n c u b a t i o n  b u f f e r  ( 6 3
mM Tris-HCl [pH 6.8]). The precipitated material was
solubilized by heating (95°C for 5 min) with a reducing-
electrophoresis sample buffer (50 mM Tris-HCl pH6.8,
2% SDS, 0.1% bromophenol blue, 5% 2-mercatoethanol,
and 10% glycerol) and further analyzed by SDS-PAGE
(12%) and fluorography. At least two independent experi-
ments were performed to obtain the reproducible results.
Enzyme-Linked Immunosorbent Assay (ELISA) for 
quantification of E protein
Samples from each fraction were diluted in coating buffer
(0.1 M Na2CO3  [pH 9.6]) and used to coat 96-well
microplates (Corning, Costar 9018) by overnight incuba-
tion at 4°C. Following incubation, the samples were
blocked using 3% bovine serum albumin (BSA) for 2 h at
room temperature, and the solid phase was then reacted
with mAb E3.3 (anti-E monoclonal antibody; 1:500 dilu-
tion) for 2 h at room temperature. The bound antibodies
were detected following incubation with the anti-mouse
IgG conjugated to peroxidase (KPL; 1:2000 dilution) for 1
h at room temperature. The ELISA products were devel-
oped using a chromogen solution containing 2, 2'-azino-
di-(3-ethylbenzthiazoline-6-sulfonate; ABTS) and hydro-
gen peroxide and their absorbance values were measured
at 405 nm. The levels of E proteins were calculated from
the absorbance values by comparison with a standard
curve established with purified domain III, which also
reacted with mAb E3.3 at a known protein concentration
[18]. The ELISA data were further normalized with the
relative total E protein expression level, which was
achieved by treating the baculovirus-infected Sf9 cells
with 10 μg/ml Brefeldin A (Merck), a fungal macrolide
antibiotic which disassembly the golgi compartment and
blocks the secretion. The relative total E protein expres-
sion level was determined by the intensity of Western
blotting bands with software Gel-Pro Analyzer (Media
Cybernetics).
Transmission electronic microscopy with immuno-gold 
labeling
The culture supernatants of the baculovirus-infected Sf9
cells (MOI = 2.5) or JEV-infected Sf9 cells at 5 dpi were
centrifuged, precipitated using 10% polyethylene glycol
(PEG)- 8,000, and then resuspended in 1 ml TN buffer
(10 mM Tris-HCl pH7.5, 100 mM NaCl). The suspen-
sions were subjected to centrifugation in a continuous
sucrose gradient (3-60% wt/wt) at 38,000 rpm for 24 h at
4°C (RPS40ST rotor, HITACHI 85P-72 ultracentrifuge).
The virus particles were collected from the fractions in 13
tubes with volumes of 0.85 mL for transmission electron
microscopy (TEM). A single-droplet negative staining
procedure was used for TEM visualization. Sample drop-
lets of 30 μL were absorbed for 10 min onto Formvar car-
bon-coated copper grids (200 mesh; Agar scientific),
washed in distilled water, and then stained with 2% uranyl
acetate for 1 min. After drying in air, the negatively-
stained samples were labeled with anti-prM mAb 5B1 or
anti-E mAb E3.3 for 1 h, and then with anti-mouse IgG
conjugated with 5 nm gold nanoparticles for 1 hr. The
prepared grids were examined in a HITACHI H-7500
TEM at 100 kV.
Results
Expression of prM proteins with inserted alanine in co-
infected Sf9 cells
The prM anchor region of the JEV 2195 strain contains
the prM-TM1 (residues prM131-147) and prM-TM2 (resi-
dues prM153-167) segments [7] (Fig. 2); these two segments
can form helix-helix complexes in lipid bilayers. Since
alanine insertion scanning mutagenesis is typically used
to identify the residues critical for helix-helix interactions
[21,22], we constructed a series of prM mutants with ala-
nine inserted in the prM-TM1 and prM-TM2 segments
including prM139, prM143, prM147, prM157, prM161,
and prM165 (Fig. 2). The positions of alanine insertion in
the prM-TM1 and prM-TM2 segments were adopted
from a previous study on helix-helix interactions in the
anchor region of the YFV prM protein [14]. In this study,
we investigated the potential role of the TM domains of
the JEV prM protein in prM-E heterodimerization as well
as in SP formation. The analyses were conducted using a
baculovirus expression system with prM and E expressed
in trans. The signal peptide of E protein is located at the
C-terminal end of prM protein, approximately in the
prM-TM2 region. Use of the prM and E coexpression in
trans  provides the advantage to study the prM TM
domains without affecting the signal peptide of E protein
for E protein expression, translocation, and the interac-
tions with prM as a heterodimeric complex formation as
we reported previously [7].
To demonstrate that the prM proteins with inserted
alanine did not influence the expression or subcellularLin et al. Journal of Biomedical Science 2010, 17:39
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localization of the prM-E interaction, Sf9 cells were co-
infected with Bac-prM (wild-type and mutants) and Bac-
E at MOI = 5. These alanine-inserted mutations in the
prM-TM1 and prM-TM2 segments did not affect the
total expression of E and prM proteins in the co-infected
Sf9 cells (Fig. 3A). The mRNA transcript levels of prM
and E of the prM mutants in the co-infected Sf9 cells
were similar as measured by using RT-quantitative real
time PCR methods (Fig. 3B). Furthermore, the cell lysates
of the co-infected Sf9 cells treated with PNGaseF or
EndoH enzymes did not show differences in their glyco-
protein patterns in SDS-PAGE gels, suggesting these ala-
nine-inserted prM mutants also did not affect the
intracellular localization of mutant prM proteins (Fig. 4).
The intracellular localization of the alanine-inserted prM
proteins was further confirmed using confocal laser scan-
ning microscopy . Sf9 cells that were infected with Bac-
prM (wild type) or Bac-prM (alanine-insertion mutants)
were doubly stained with a prM-specific MAb and DiC,
an ER-specific dye. The doubly stained images obtained
by confocal laser scanning microscopy indicated that the
intracellular distributions of prM and the prM proteins
with inserted alanine almost overlapped with the ER
marker (Fig. 5). Thus, none of the prM mutants with
inserted alanine influenced the expression or subcellular
localization of the prM protein in the co-infected Sf9
cells.
Effects of prM proteins with inserted alanine on prM-E 
heterodimerization in co-infected Sf9 cells
To investigate the alanine-inserted prM mutants affecting
prM-E heterodmerization, Sf9 cells co-infected with Bac-
prM (wild type or alanine-insertion mutants) and Bac-E
were radiolabelled with [35S]methionine-cysteine
medium for 24 h, purified using sucrose gradient sedi-
mentation, and immunoprecipitated by an E-specific
mAb. The results in SDS-PAGE gels showed that the two
reactive bands (corresponding to prM of 21 kDa and E of
56 kDa) were present in sucrose gradient fractions 5 and
6 of the co-infected Sf9 cells with Bac-prM (wild type)
(Fig. 6A), Bac-prM A139 (Fig. 6B), Bac-prM A143 (Fig.
Figure 2 Positions of the alanine insertion mutations in the two transmembrane regions (TM1 and TM2) of prM protein of JEV CH2195LA 
strain. A series of mutants was constructed; Bac-prM, Bac-prM A139, Bac-prM A143, Bac-prM A147, Bac-prM A157, Bac-prM A161 and Bac-prM A165. 
Arrows indicate the positions of alanine insertion.Lin et al. Journal of Biomedical Science 2010, 17:39
http://www.jbiomedsci.com/content/17/1/39
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Figure 3 (A) The total expression of prM and E proteins in Sf9 cells co-infected with Bac-prM (wild type and mutants A139, A143, A147, 
A157, A161, A165) and Bac-E. GAPDH was measured as an internal control; (B) The mRNA transcript levels of prM and E in the co-infected Sf9 cells 
measured by real-time RT-qPCR. The wt prM/E expression level was taken as 100%.
Figure 4 Treatment of recombinant prM with endoglycosidase PNGaseF and EndoH. The prM mutants with inserted alanine were treated with 
PNGaseF (P) and EndoH (E) to analyze the presence and composition of their N-linked glycans.Lin et al. Journal of Biomedical Science 2010, 17:39
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6C), Bac-prM A147 (Fig. 6D), Bac-prM A157 (Fig. 6E),
Bac-prM A161 (Fig. 6F) and Bac-prM A165 (Fig. 6G).
However, the intensity of binding to the prM-E complex
by some prM mutants with inserted alanine differed from
the wild type prM. For instance, a smaller amount of E
protein was precipitated when coexpressed with prM
A143, prM A147, or prM A165, compared to those of E
protein when coexpressed with the WT or other mutant
prM proteins. To characterize these mutations in the
prM-TM1 and prM-TM2 that affected the association
between E and prM, the percentage of heterodimeriza-
tion of prM to E was taken as the prM/E ratio. The prM/E
ratio was measured for the stable prM-E complex in each
sucrose gradient fractionation to minimize the differen-
tial precipitation efficiency in each sample. Also a side-
by-side comparison of the total levels of E and prM prior
to precipitation was also conducted where we did not
find differences of prM and E expression for the WT and
mutants (data not shown). The prM/E ratios in the
sucrose gradient fractions 4 to 6 were 100% (Bac-prM),
86% (Bac-prM A139), 51% (Bac-prM A143), 61% (Bac-
prM A147), 77% (Bac-prM A157), 75% (Bac-prM A161),
and 87% (Bac-prM A165) (Fig. 7). The Bac-prM A143
mutant most reduced the formation of prM-E heterodim-
ers in infected cells.
Effects of prM proteins with inserted alanine on SP 
formation in co-infected Sf9 cells
To further evaluate the SP formation affected by the ala-
nine-inserted prM mutants, culture supernatants were
collected from Sf9 cells that were co-infected with Bac-
prM (wild type or alanine-insertion mutants) and Bac-E,
purified using sucrose gradient sedimentation, and the E
protein concentration in each sucrose fraction was mea-
sured by ELISA. The results showed that much less SP
was formed in Sf9 cells that were infected with any of the
prM mutants with inserted alanine than wild type Bac-
prM (Fig. 8A-G). The release of SP from Sf9 cells that
were co-infected with the wild-type Bac-prM (Fig. 8A)
was verified by TEM using immuno-gold labeling with
the anti-E mAb E3.3 (Fig. 8H) and the anti-prM mAb 5B1
(Fig. 8I). Quantification of the SP release from the co-
infected Sf9 cells was determined by calculating the
underneath area of the E protein concentrations. The
results were further normalized to the total E protein
expression of the same co-infected cells treated with
brefeldin A to prevent SP release (Fig. 8J). Thus, the per-
centage of SP release in the co-infected cells was calcu-
lated from the underneath area of sucrose gradient
fractions of culture supernatants of the co-infected Sf9
cells and the value was normalized to the total E protein
Figure 5 Observation of subcellular localization using confocal laser scanning microscopy. The subcellular location of wild type and mutant 
prM was visualized by double-staining of the infected Sf9 cells. The ER compartment was stained with 10 nM DiIC13(3), and the prM proteins were 
stained with mAb 5B1, followed by goat anti-mouse Alexa Fluor 647 IgG. Photographs were taken with appropriate excitation laser wavelengths and 
merged to reveal the co-localization of prM and ER compartment.Lin et al. Journal of Biomedical Science 2010, 17:39
http://www.jbiomedsci.com/content/17/1/39
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Figure 6 Sucrose gradient sedimentation analysis of alanine-insertion mutagenesis of the anchor region of prM protein. Sf9 cells were coin-
fected with Bac-E and Bac-prM mutants. Cell lysates labeled with [35S] were applied for centrifugation in a 3 to 60% (wt/wt) sucrose gradient. Each 
fraction was immunoprecipitated with monoclonal antibody E3.3. The immune complexes were analyzed by reducing SDS-PAGE and fluorography. 
(A) Sf9 cells coinfected with Bac-prM and Bac-E; (B) Sf9 cells coinfected with prM A139 and Bac-E; (C) Sf9 cells coinfected with prM A143 and Bac-E; (D) 
Sf9 cells coinfected with prM A147 and Bac-E; (E) Sf9 cells coinfected with prM A157 and Bac-E; (E) Sf9 cells coinfected with prM A157 and Bac-E; (F) 
Sf9 cells coinfected with prM A161 and Bac-E; (G) Sf9 cells coinfected with prM A165 and Bac-E. The data presented in this figure are three independent 
experiments.Lin et al. Journal of Biomedical Science 2010, 17:39
http://www.jbiomedsci.com/content/17/1/39
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contents measured in brefeldin A-treated Sf9 cells. The
results showed the percentage of SP release dropped from
100% (Bac-prM) to 27% (Bac-prM A139), 22% (Bac-prM
A143), 26% (Bac-prM A147), 29% (Bac-prM A157), 34%
(Bac-prM A161), and 39% (Bac-prM A165) (Fig. 9). All
the prM mutants with inserted alanine resulted in signifi-
cant impairment for the formation of SP in baculovirus-
infected Sf9 cells, suggesting that the two TM domains of
prM may play important roles for the formation and
release of SP.
Glycine substitution mutagenesis in the prM-TM1 segment
To further characterize the prM A143 mutant that influ-
enced the prM-E interaction, the prM-TM1 sequences
were analyzed and a GXXXG motif was identified at resi-
dues 142-146 (G142WMLG146S147) (see Fig. 1). The
GXXXG motif contains amino acids that are hydrophobic
and commonly present in many TM proteins [23]. There-
fore the glycine at residues 142 and/or 146 were replaced
with alanine, leucine or valine, respectively, to demon-
strate the specificity of the GXXXG motif (Bac-prM
G142A, Bac-prM G142L, Bac-prM G142V, Bac-prM
G146A, Bac-prM G146L, Bac-prM G146V) (Fig. 10).
Similarly, these GXXXG mutants did not affect the total
expression of E and prM proteins in the co-infected Sf9
cells (Fig. 11A). The mRNA transcript levels of prM and E
of these GXXXG mutants in the co-infected Sf9 cells
were around the same as measured by using RT-quantita-
tive real time PCR methods (Fig. 11B). However, the per-
centage of heterodimerization of prM to E for
characterization of the mutations that affected the associ-
ation between E and prM revealed the glycine substitutes
at 142 and 146 by alanine, leucine or valine reduced by
approximately 50%, except the mutant G142A giving a
25% loss (Fig. 12). Therefore, both glycine residues in the
GXXXG-motif of the prM-TM1 segment are equally
important to the formation of a stable prM-E complex.
Sequence alignment analysis of TM regions of prM proteins 
of different flavivirus groups
The amino acid sequence alignments of the prM TM
regions of 5 groups of flaviviruses, including JEV sero-
complex viruses (JEV, KUNV, MVEV, SLEV, WNV), four-
serotype dengue viruses (DENV-1, DENV-2, DENV-3,
DENV-4), TBEV, and YFV were analyzed to determine
whether the GXXXG motif was conserved. These
sequences were aligned and analyzed using the Show-
align program from Jemboss on the Jemboss server http:/
/bioinfo.life.nthu.edu.tw/bioinfo.htm. Additional file 1
summarizes the results, which show that the amino acid
sequences of the prM-TM1 are nearly identical except
amino acid 140 in three strains of JEV but vary among
other JEV serocomplex viruses, DENV-1, DENV-2,
DENV-3, DENV-4, TBEV, and YFV. However, the
GXXXG motif is present in all JEV serocomplex viruses.
Discussion
The flavivirus assembly process is driven mainly by the
interactions between two envelope proteins prM and E.
Co-expression of these two proteins in cultured cells can
yield recombinant SPs. In this work, alanine insertion and
site-directed mutagenesis were employed to study the
influence of the TM anchor region of prM protein on the
formation of prM-E heterodimers and SP production.
The results show that the GXXXG motif present in the
prM-TM1 domain is the element that affects the forma-
tion of prM-E heterodimers. Both TM segments of the
prM protein are crucial for SP formation and release.
Alanine-insertion mutagenesis was employed to dis-
rupt the TM helical structures in the TM anchor regions
of prM protein (prM-TM1 and prM-TM2) in experi-
ments. Six prM mutants with inserted alanine (prM139A,
prM143A, prM147A, prM157A, prM161A, prM165A)
were used; the insertion sites were chosen according to a
study of alanine insertion mutagenesis of the TM pro-
teins of YFV [14]. This insertion mutagenesis has been
applied for identifying critical segments of TM region
involved in helix-helix interactions [21,22,24]. These
mutated proteins may also have subtle alternations in
protein stability, expression, folding, and translocation.
Baculovirus insect cell expression has been widely used to
express complex proteins particularly requiring post-
translational modifications [25]. In this study we
employed a baculovirus coexpression system with prM
and E expressed in trans where alanine insertion and sub-
Figure 7 prM-E heterodimerization of prM mutants with inserted 
alanine as a percentage of the binding intensity of wild type prM. 
Each prM to E ratio was calculated. The wild type prM/E ratio was taken 
as 100% in evaluating the mutant prM-E binding affinity. Each data rep-
resents the average of the experiments for a single prM mutant and 
the error is standard deviation. The positions of the alanine insertions 
in the TM region of prM are indicated.Lin et al. Journal of Biomedical Science 2010, 17:39
http://www.jbiomedsci.com/content/17/1/39
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stitution mutagenesis of prM-TM1 and prM-TM2 frag-
ments were conducted to study the interactions of prM
and E proteins in co-infected Sf9 cells. Our results show
that a series of alaine inserted prM mutants neither
affected the mRNA and protein expression levels of prM
nor the subcellular localization of the prM protein in Sf9
cells. However, whether these prM mutants may alter
anchorage of mutant prM proteins into membranes or
cause a conformational change of the extracellular
domain of prM are still required for further confirmation.
Among these alanine-inserted prM mutants, the prM-
143A mutant within the GXXXG motif in the prM-TM1
segment markedly reduced the formation of the prM-E
heterodimers by up to 50%. This result is consistent with
our earlier study using C-terminal truncation, which
showed a reduction of the formation of the prM-E com-
plex by approximately 40% for the TM1 of prM protein,
as compared to the complete abolishment of the interac-
tions by the prM His-99 mutation [7].
The impairment of SP formation but a modest disrup-
tion of prM-E heterodimerization by all prM mutants
with inserted alanine was observed in our study. For
example, the mutant prM165 exhibited an interaction
profile nearly identical to wild type in the prM-E het-
erodimerization (Fig. 7), yet had a significant effect on SP
release (Fig. 9). Conversely, mutants with a more "dra-
Figure 8 Alanine-insertion mutagenesis of the TM regions of prM protein: effect on SP formation. Recombinant SPs secreted from Sf9 cells co-
infected with with Bac-E and (A) Bac-prM; (B) Bac-prM A139; (C) Bac-prM A143; (D) Bac-prM A147; (E) Bac-prM A157; (F) Bac-prM A161, and (G) Bac-prM 
A165 were quantified by ELISA. The size and shape of the secreted recombinant SP were observed by TEM using immuno-gold labeling with (H) mAb 
E3.3 and (I) and mAb 5B1. (J) The total E protein in Sf9 cells was determined in the presence of Brefeldin A, a fungal a fungal macrolide antibiotic which 
blocks E protein secretion. GAPDH was taken as an internal loading control.
Figure 9 Quantification of the SP release was determined by cal-
culating the underneath area of the E protein concentrations 
from fractions 7 to 10 in Fig. 7 A-G. The underneath areas were nor-
malized by the corresponding total amount of E protein in Fig 7J and 
the percentage of SP release represented the relative value of each 
prM mutant (Fig. 7B-G) compared to the wild type (Fig. 7A)Lin et al. Journal of Biomedical Science 2010, 17:39
http://www.jbiomedsci.com/content/17/1/39
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matic" reduction in the interaction between prM and E
displayed similar reductions in the release of SP. Muta-
tions in the two prM TM segments may increase the het-
erogeneity of SP, as evidenced by the broader peak of E
protein in these mutants (Fig. 8B-G). The broaden frac-
tions of SPs from prM mutants may come from E protein
itself to form an oligomer and release into culture
medium through envelopment by vesicles. However, the
total E protein contents measured in the same infected
cells treated with Brefeldin A, a fungal macrolide antibi-
otic to disassembly the Golgi compartment and block the
SP secretion, had similar levels among the wild type and
prM mutants (Fig. 8J). These results indicate that the
assembly, budding and secretion of SP are not only deter-
mined by the interactions among the prM and E envel-
oped proteins but also several post-assembly events such
as budding and secretion. The newly synthesized prM
and E enveloped proteins can associate to form homo- or
hetero-dimeric/oligomeric complexes which can not be
incorporated into an icosahedral lattice for budding into
the ER lumen. The final stage of SP release in the infected
cells still requires a rapid transport along the compart-
ments of the secretory pathway. It was reported that
some of the prM mutations located outside the TM
region in DENV and TBE hardly affected the prM-E het-
erodimerization but greatly inhibited the SP secretion
[26,27]. The SP release through envelop budding is driven
by multimerization of the envelope proteins prM and E to
create an icosahedral lattice which is composed by 60
asymmetric trimers of prM-E heterodimers [28]. Then
the prM-E heterodimers, transient contacts between prM
TM domains occurred during the budding process, disso-
ciate due to the major rearrangement into the E:E dimers
during the maturation process of the particles after cleav-
age of prM by a furin in the trans Golgi network [29]. Fur-
ther investigation of SP budding and secretion
particularly in late-step secretory pathways are required
to understand the detailed mechanisms of flavivirus
assembly, exit, and maturation.
The GXXXG motif in the prM-TM1 segment of the JEV
2195LA strain was further studied using site-specific
mutagenesis to demonstrate its specificity for helix-helix
interaction in the TM anchor regions. Replacing the gly-
cine residues in the GXXXG motif with three other small
amino acids (alanine, leucine and valine), supporting
extensive interhelical van der Waals interactions, indi-
cated that the two glycine residues were equally impor-
tant to the formation of prM-E heterodimers (Fig. 12).
This site-specific mutagenesis result is consistent with
the previously reported effect of the GXXXG motif on
the formation of the E1:E2 heterdimer in hepatitis C virus
and Semliki Forest virus [24,30,31]. However, virus
assembly depends on a replacement by leucine of the
conserved glycine residues in the GXXXG motif in Sem-
liki Forest virus [32]. Thus, the importance of the con-
served glycine residues in the TM anchor regions may
Figure 10 Characterization of the GXXXG motif of the TM1 region of the prM protein by glycine-substitution mutagenesis. Glycine residues 
at 142 and 146 were substituted by alanine, leucine, or valine to investigate the relationship between the GXXXG motif and the prM-E binding affinity.Lin et al. Journal of Biomedical Science 2010, 17:39
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vary with the variations in amino acid sequence among
virus species.
The topology of the TM regions of enveloped proteins
of enveloped viruses has been recently revealed for the
enveloped protein heterodimerization and the SP forma-
tion, but with inconclusive results [14,24,31,33,34]. In an
earlier study on YFV, the alanine insertions did not affect
prM-E heterodimerization but greatly impaired the SP
release of YFV [13]. Alanine insertion within the center of
the TMDs of E1 or E2 or in the N-terminal part of the
TMD of E1 dramatically affected for 60-90% reduction of
hepatitis C virus envelope glycoproteins [24]. Even the
E1-E2 heterodimerization was not affected, some
mutants still showed reduced HCVpp infectivity [31].
The differences among these viruses may be due to their
similar topology of TM region of envelope proteins. The
TM regions of prM and E proteins of flaviviruses are
potentially longer than their counterpart in HCV [13,33].
Further sequence alignment analysis of the anchor
regions of prM proteins of various flaviviruses, shown in
Additional file 1, indicates that the LGXXLG motif is
present in the TM1 region of JEV and MVE; the IGXXLG
motif in KUNV, SLEV and WNV; the LAXXIG motif in
DENV-1 to DENV-4; and the IAXXVG motif in the YFV.
As revealed by a statistical analysis of the anchor regions
of TM proteins, most of the amino acid patterns of small
residues (Gly, Ala and Ser) at i and i+4 are associated with
large aliphatic residues (Ile, Val and Leu) at neighboring
positions (i.e. i+/-1 and i+/-2) in the TM anchor regions
Figure 11 (A) The total expression of prM and E proteins in Sf9 cells co-infected with Bac-prM (wild type and mutants G142A, G142L, 
G142V, G146A, G146L, G146V) and Bac-E. GAPDH was measured as an internal control; (B) The mRNA transcript levels of prM and E in the co-in-
fected Sf9 cells measured by real-time RT-qPCR. The wt prM/E expression level was taken as 100%.
Figure 12 The percentage of the binding intensity of wild type 
prM. Each prM to E ratio was calculated where wild type prM/E ratio 
was taken as 100% in evaluating the glycine-substituted mutant prM-
E binding affinity. Each data represents the average of the experiments 
for a single prM mutant and the error is standard deviation.Lin et al. Journal of Biomedical Science 2010, 17:39
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[35]. Sequence alignment analysis of the anchor regions
of prM proteins of various flaviviruses indicates that the
prM-TM1 domain of YFV contains AYLVG residues
rather than the GXXXG motif. Furthermore, the con-
necting segment between prM-TM1 and prM-TM2
domains of JEV prM proteins has four hydrophilic resi-
dues and one charged residue (NNGQR). Replacing the
arginine (R) residue with alanine in the prM connected
segment did not affect the prM-E heterodimerization and
SP formation (data not shown). The data on SP inhibition
by prM insertion mutants in the two TM segments but
not the connecting segment suggest that the prM-TM1
and prM-TM2 domains may play importation roles in the
formation and release of the JEV particle assembly.
Conclusion
In this study, we characterized the involvement of JEV
prM TM1 and TM2 region in the prM-E heterodimeriza-
tion and the assembly of subviral particles. Furthermore,
we identified a conserved GXXXG motif in the prM TM1
region of the JEV serocomplex viruses, which may play an
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